| Schedule of Common Stock Reserved for Future Issuances |
The Company had reserved the following number of shares of common stock for the exercise of outstanding warrants, exercise of outstanding pre-funded warrants, exercise of outstanding stock options, settlement of outstanding RSUs and PRSUs, and future issuances of stock-based awards:
|
|
|
|
|
|
|
|
|
|
|
March 31, 2026 |
|
|
December 31, 2025 |
|
Warrants to purchase shares of common stock |
|
|
13,009,536 |
|
|
|
13,876,838 |
|
Pre-funded warrants to purchase shares of common stock |
|
|
7,346,269 |
|
|
|
7,346,269 |
|
Options to purchase shares of common stock under the 2021 Plan and 2023 Plan |
|
|
6,355,064 |
|
|
|
4,396,860 |
|
RSUs and PRSUs subject to settlement in shares of common stock under the 2023 Plan |
|
|
1,494,812 |
|
|
|
844,278 |
|
Shares available for issuance under the 2023 Plan |
|
|
3,007,796 |
|
|
|
2,132,156 |
|
Shares available for issuance under the 2023 ESPP |
|
|
1,158,154 |
|
|
|
733,239 |
|
Shares available for issuance under the 2025 Inducement Equity Plan |
|
|
2,000,000 |
|
|
|
2,000,000 |
|
Total shares of common stock reserved for future issuance |
|
|
34,371,631 |
|
|
|
31,329,640 |
|
|